Tazeen Ahmad
Stock Analyst at B of A Securities
(1.06)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Downgrades: Neutral | 76 28 | 17.1 | 63.74% | 22 | Jun 16, 2025 | |
ASND Ascendis Pharma | Maintains: Strong Buy | 201 216 | 171.99 | 25.59% | 10 | Jun 9, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Neutral | 18 23 | 22.09 | 4.12% | 14 | Jun 5, 2025 | |
PRTA Prothena Corp | Downgrades: Underperform | 22 4 | 6.09 | -34.32% | 6 | May 28, 2025 | |
STRO Sutro Biopharma | Maintains: Underperform | 1 1 | 0.76 | 5.26% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 27 | 14.09 | 91.63% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 41 23 | 17.43 | 31.96% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 55 68 | 49.79 | 36.57% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 63 68 | 62.59 | 8.64% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 302 325 | 322.64 | 0.73% | 3 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 54 28 | 7.53 | 271.85% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 73 70 | 52.94 | 32.23% | 5 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 42 40 | 3.83 | 944.39% | 4 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 184 179 | 125.44 | 42.7% | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 11.41 | 92.81% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 6 3 | 1.14 | 163.16% | 3 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 68 90 | 68.36 | 31.66% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 13 15 | 5.94 | 152.53% | 5 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 11 6 | 9.15 | -34.43% | 14 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 125 150 | 106.77 | 40.49% | 7 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 10 2 | 7.08 | -71.75% | 6 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 535 607 | 559.65 | 8.46% | 3 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 83 76 | 36.51 | 108.16% | 6 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 4 | 250% | 2 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 2.4 | 316.67% | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 2 6 | 1.03 | 482.52% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 9.24 | 62.34% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | n/a | n/a | 2 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 7 1 | n/a | n/a | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 8 11 | 17.03 | -35.41% | 3 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 36 31 | n/a | n/a | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 10 | 9.36 | 6.84% | 6 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 7 2 | 2.7 | -25.93% | 2 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 2 7 | n/a | n/a | 3 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 90 20 | n/a | n/a | 2 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 6 | 0.81 | 640.74% | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 75 15 | 9.01 | 66.48% | 3 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 390 60 | 42.97 | 39.63% | 2 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 23 | n/a | n/a | 2 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 16 | 1.11 | 1341.44% | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 2 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 20 | n/a | n/a | 2 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 13 5 | n/a | n/a | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 43 | 9.84 | 336.99% | 2 | Sep 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 45 47 | n/a | n/a | 2 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 6 | n/a | n/a | 4 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 233 227 | n/a | n/a | 4 | Feb 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 3 | Sep 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 4 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 330 300 | 9.21 | 3157.33% | 1 | Nov 2, 2018 |